Metabolic syndrome, hepatic steatosis, and cardiovascular risk in children.

Abstract

OBJECTIVES Pediatric metabolic syndrome (MetS) is a well-recognized entity; however, there is no consensus on its exact value in predicting long-term cardiovascular (CV) risk. Hepatic steatosis (HS) is another emerging condition associated with pediatric obesity, and data have been reported suggesting a possible role of HS in CV risk linked to MetS. The aim… (More)
DOI: 10.1016/j.nut.2016.10.017

Topics

Cite this paper

@article{Rutigliano2017MetabolicSH, title={Metabolic syndrome, hepatic steatosis, and cardiovascular risk in children.}, author={Irene Rutigliano and Roberta Vinci and Gianpaolo De Filippo and Monica Mancini and Luca Pio Stoppino and M D'apolito and Ida Giardino and Luca Macarini and Massimo Pettoello Mantovani and Angelo Campanozzi}, journal={Nutrition}, year={2017}, volume={36}, pages={1-7} }